PHARMIDEX PHARMACEUTICAL SERVICES LIMITED
Company number 04441512
- Company Overview for PHARMIDEX PHARMACEUTICAL SERVICES LIMITED (04441512)
- Filing history for PHARMIDEX PHARMACEUTICAL SERVICES LIMITED (04441512)
- People for PHARMIDEX PHARMACEUTICAL SERVICES LIMITED (04441512)
- Charges for PHARMIDEX PHARMACEUTICAL SERVICES LIMITED (04441512)
- More for PHARMIDEX PHARMACEUTICAL SERVICES LIMITED (04441512)
| Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
|---|---|---|---|
| 24 May 2024 | CS01 | Confirmation statement made on 17 May 2024 with no updates | |
| 24 May 2024 | AD04 | Register(s) moved to registered office address 167-169 Great Portland Street Fifth Floor London W1W 5PF | |
| 10 Apr 2024 | AA | Total exemption full accounts made up to 31 December 2022 | |
| 17 Jan 2024 | AA01 | Current accounting period shortened from 30 June 2023 to 31 December 2022 | |
| 22 Dec 2023 | CH01 | Director's details changed for Professor Mohammad Sadeghi Alavijeh on 22 December 2023 | |
| 20 Dec 2023 | AD04 | Register(s) moved to registered office address 167-169 Great Portland Street Fifth Floor London W1W 5PF | |
| 20 Dec 2023 | AD04 | Register(s) moved to registered office address 167-169 Great Portland Street Fifth Floor London W1W 5PF | |
| 29 Aug 2023 | AA | Total exemption full accounts made up to 30 June 2022 | |
| 20 Jun 2023 | AA01 | Previous accounting period shortened from 31 December 2022 to 30 June 2022 | |
| 19 May 2023 | CS01 | Confirmation statement made on 17 May 2023 with no updates | |
| 29 Mar 2023 | AA | Total exemption full accounts made up to 31 December 2021 | |
| 11 Jan 2023 | AA01 | Current accounting period shortened from 30 June 2022 to 31 December 2021 | |
| 02 Nov 2022 | AA | Total exemption full accounts made up to 30 June 2021 | |
| 13 Oct 2022 | PSC05 | Change of details for Pharmidex Holdings Ltd as a person with significant control on 13 October 2022 | |
| 13 Oct 2022 | AD01 | Registered office address changed from 167-169 Great Portland Street Fifth Floor London W1W 5PF United Kingdom to 167-169 Great Portland Street Fifth Floor London W1W 5PF on 13 October 2022 | |
| 13 Oct 2022 | AD01 | Registered office address changed from Office 3.05 1 King Street London EC2V 8AU England to 167-169 Great Portland Street Fifth Floor London W1W 5PF on 13 October 2022 | |
| 18 Aug 2022 | AA01 | Current accounting period shortened from 31 December 2021 to 30 June 2021 | |
| 24 May 2022 | CS01 | Confirmation statement made on 17 May 2022 with no updates | |
| 24 Feb 2022 | AA | Total exemption full accounts made up to 31 December 2020 | |
| 14 Dec 2021 | AA01 | Previous accounting period shortened from 30 June 2021 to 31 December 2020 | |
| 29 Sep 2021 | AA | Total exemption full accounts made up to 30 June 2020 | |
| 30 Jun 2021 | AA01 |
Current accounting period shortened from 31 December 2020 to 30 June 2020
|
|
| 17 Jun 2021 | AA | Total exemption full accounts made up to 31 December 2019 | |
| 26 May 2021 | CS01 | Confirmation statement made on 17 May 2021 with no updates | |
| 30 Sep 2020 | PSC05 | Change of details for Pharmidex Holdings Ltd as a person with significant control on 1 September 2020 |